Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 1, 2008, Pages 71-75

  Nomoto, Kazuhiro ^a   Tsuneyama, Koichi ^a   Takahashi, Hiroyuki ^a   Murai, Yoshihiro ^a   Takano, Yasuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

8 hydroxydeoxyguanosine; Immunohistochemistry; Nonalcoholic fatty liver disease

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CELL GRANULE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE MARKER; DNA DAMAGE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL; MALE; MITOCHONDRION; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STEATOSIS;

ADULT; AGED; CYTOPLASMIC GRANULES; DEOXYGUANOSINE; DNA DAMAGE; DNA, MITOCHONDRIAL; FATTY LIVER; FEMALE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 37549030853     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31803156d5     Document Type: Article

References (21)

1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37:1202-1219.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231.
3. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001;121:710-723.
4. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-2474.
5. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3-16.
6. Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis. 2002;6:399-420.
7. Day CP, James OF. Steatohepatitis: a table of two "hits"? Gastroenterology. 1998;114:842-845.
8. Berson A, De Beco V, Letteron P, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology. 1998;114:764-774.
9. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res. 1997;387:147-163.
10. Seki S, Kitada T, Yamada T, et al. Immunohistochemical detection of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, in human chronic cholecystitis. Histopathology. 2002;40:531-535.
11. Seki S, Kitada T, Yamada T, et al. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol. 2002;37:56-62.
12. Seki S, Kitada T, Sakaguchi H, et al. Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology. 2003;42:365-371.
13. Matsumoto K, Satoh Y, Sugo H, et al. Immunohistochemical study of the relationship between 8-hydroxy-2′-deoxyguanosine levels in noncancerous region and postoperative recurrence of hepatocellular carcinoma in remnant liver. Hepatol Res. 2003;25:435-441.
14. Sreekumar R, Rosado B, Rasmussen D, et al. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology. 2003;38:244-251.
15. Kitada T, Seki S, Iwai S, et al. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol. 2001;35:613-618.
16. Kumada T, Tsuneyama K, Hatta H, et al. Improved one-hour rapid immunostaining method using intermittent microwave irradiation: practicability based on five years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol. 2004;17:1141-1149.
17. Tsuneyama K, Harada K, Yasoshima M, et al. Monocyte chemotactic protein-1, 2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implication for pathogenesis. J Pathol. 2001;193:102-109.
18. Warita H, Hayashi T, Murakami T, et al. Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice. Brain Res Mol Brain Res. 2001;89:147-152.
19. Wakabayashi T. Megamitochondria formation-physiology and pathology. J Cell Mol Med. 2002;6:497-538.
20. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183-1192.
21. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A. 1988;85:6465-6467.